Details for 2021727630
Up to date per 03.04.2026
Actions
Details for 2021727630
Deleted
European Patent
08.03.2023 A
20.08.2025 B1
28.04.2020
US
202063016886 P
A61K 31/55 20060101AFI20211105BHEP
Owner
Oyster Point Pharma, Inc.202 Carnegie Center, Suite 109 Princeton, New Jersey 08540US
Representative
No representatives present
Inventor
NAU, Jeffrey Alan Princeton, New Jersey 08540US
CARLSON, Eric C Burleson, Texas 76028US